Abstract
Parasitological, haematological, immunological and clinical examinations were carried out on 29 Guatemalan patients with onchocerciasis. The patients were given diethylcarbamazine (DEC) treatment (5 mg/kg/day for 7 days) and then examined clinically the adverse reactions at 3, 12, 24, 48 and 72 hours after the initial administration of DEC. The essential features of the adverse reactions elicited by DEC administration were pruritus, rash, pain, lymphadenopathy and edema. The severity of those reactions was found to be roughly proportional to the eosinophil counts in blood and/or the serum level of Onchocerca volvulus-antigen specific IgG.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
